Expanding Facility Network Eurofins CDMO Europe is actively expanding its facilities, including a new laboratory in Switzerland, signaling opportunities to offer advanced analytical and testing services to a broader client base seeking scalable development and manufacturing solutions.

Innovative Technology Adoption The company's recent launch of electrochemical impedance spectroscopy and monochromated electron energy loss spectroscopy demonstrates a commitment to advanced analytical capabilities, creating potential sales avenues for clients needing cutting-edge characterization and failure analysis services.

Asset Sales and Focus The divestment of the electrical and electronics testing business to UL Solutions frees up resources and highlights a strategic focus on biopharmaceutical drug development, presenting opportunities to cross-sell specialized API, formulation, and GMP manufacturing services to pharma clients.

Regulatory Expertise Eurofins CDMO’s accreditation with multiple regulatory agencies positions it as a trusted partner for pharmaceutical companies needing compliance support throughout development and manufacturing, offering prospects to provide regulatory consulting and CMC support services.

Collaborations & Partnerships Recent strategic collaborations with firms like TRI Princeton and CMP Scientific expand Eurofins’ network into clinical testing and advanced characterization, providing a pipeline of potential clients in biopharma R&D seeking comprehensive development, testing, and analytical solutions.